Pharmaxis Announces Agreement for European Supply of Bronchitol
Release Date: 29/03/2012 12:00am
Pharmaceutical company Pharmaxis (ASX: PXS) today announced it has finalised a logistics and distribution services agreement for the supply of Bronchitol across Europe. In anticipation of a second quarter commercial launch of Bronchitol for cystic fibrosis in Europe, Pharmaxis has signed a three year agreement with Arvato Healthcare, a member of the Bertelsmann AG group of companies.
Categories: News and Media